Desoximetasone 0.0005 MG/MG Topical Gel — RxCUI 315059
RxNorm drug concept · Semantic clinical drug
RxCUI 315059
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI315059
Official nameDesoximetasone 0.0005 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdesoximetasone 0.05 % Topical Gel; desoximetasone 0.5 MG per GM Topical Gel
FDA products mapped3
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Desoximetasone Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The topical spray form — sold as Topicort spray — is approved to treat plaque psoriasis in adults 18 and older. It's a strong anti-inflammatory steroid that helps reduce the rednes...
- What is desoximetasone actually used for?
- Spray a thin film directly onto the affected skin areas twice a day, then gently rub it in. Don't wrap or bandage the area afterward unless your doctor specifically tells you to —...
- The spray is meant for short-term use only — no more than 4 weeks. You should actually stop using it as soon as your skin clears up, even if that's sooner. Using a strong steroid o...
🕸️ Concept Web — How Desoximetasone 0.0005 MG/MG Topical Gel Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Desoximetasone 0.0005 MG/MG Topical Gel
RxCUI 315059 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Desoximetasone
3255IN
-
Desoximetasone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Topicort
220345BN
-
Topicort
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Desoximetasone Topical Gel
385104SCDF -
Desoximetasone Topical Product
1154232SCDG -
Desoximetasone Topical Gel [Topicort]
370385SBDF -
Topicort Topical Product
1177999SBDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Desoximetasone Topical Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Desoximetasone 0.0005 MG/MG
328232SCDC -
Desoximetasone 0.0005 MG/MG Topical Gel [Topicort]
94346SBD -
Desoximetasone 0.0005 MG/MG [Topicort]
562923SBDC
-
Desoximetasone 0.0005 MG/MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Desoximetasone 0.0005 MG/MG
SCDC · 328232 -
Desoximetasone Topical Gel
SCDF · 385104 -
Desoximetasone Topical Product
SCDG · 1154232
Brand-Name Concepts
-
Desoximetasone 0.0005 MG/MG Topical Gel [Topicort]
SBD · 94346 -
Desoximetasone 0.0005 MG/MG [Topicort]
SBDC · 562923 -
Desoximetasone Topical Gel [Topicort]
SBDF · 370385 -
Topicort Topical Product
SBDG · 1177999 -
Topicort
BN · 220345
📦 FDA Products & Package NDCs
3 products · 11 package NDCs
11 package NDCs map to RxCUI 315059 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51672-1261-01 | 1 TUBE in 1 CARTON (51672-1261-1) / 15 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1998-07-14 |
| 51672-1261-02 | 1 TUBE in 1 CARTON (51672-1261-2) / 30 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1998-07-14 |
| 51672-1261-03 | 1 TUBE in 1 CARTON (51672-1261-3) / 60 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1998-07-14 |
| 51672-1270-01 | 1 TUBE in 1 CARTON (51672-1270-1) / 15 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1270-02 | 1 TUBE in 1 CARTON (51672-1270-2) / 30 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1270-03 | 1 TUBE in 1 CARTON (51672-1270-3) / 60 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1270-07 | 1 TUBE in 1 CARTON (51672-1270-7) / 100 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1271-01 | 1 TUBE in 1 CARTON (51672-1271-1) / 15 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1271-02 | 1 TUBE in 1 CARTON (51672-1271-2) / 30 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1271-03 | 1 TUBE in 1 CARTON (51672-1271-3) / 60 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
| 51672-1271-07 | 1 TUBE in 1 CARTON (51672-1271-7) / 100 g in 1 TUBE | Desoximetasone | Sun Pharmaceutical Industries, Inc. | 1990-11-30 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (11)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.